Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

New Fissure-attached Nodules in Lung Cancer Screening: A Brief Report from The NELSON Study.

Han D, Heuvelmans MA, van der Aalst CM, van Smoorenburg LH, Dorrius MD, Rook M, Nackaerts K, Walter JE, Groen HJM, Vliegenthart R, de Koning HJ, Oudkerke M.

J Thorac Oncol. 2019 Oct 10. pii: S1556-0864(19)33521-X. doi: 10.1016/j.jtho.2019.09.193. [Epub ahead of print]

PMID:
31606605
2.

Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial.

Denissen SJ, van der Aalst CM, Vonder M, Oudkerk M, de Koning HJ.

Eur J Prev Cardiol. 2019 Aug;26(12):1313-1322. doi: 10.1177/2047487319843396. Epub 2019 Apr 9.

PMID:
30966821
3.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.

Walter JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, van der Aalst CM, Yousaf-Khan U, van Ooijen PMA, Nackaerts K, Groen HJM, De Bock GH, de Koning HJ, Oudkerk M.

Thorax. 2019 Mar;74(3):247-253. doi: 10.1136/thoraxjnl-2018-212152. Epub 2018 Dec 27.

PMID:
30591535
4.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

Walter JE, Heuvelmans MA, de Bock GH, Yousaf-Khan U, Groen HJM, van der Aalst CM, Nackaerts K, van Ooijen PMA, de Koning HJ, Vliegenthart R, Oudkerk M.

Lung Cancer. 2018 Nov;125:103-108. doi: 10.1016/j.lungcan.2018.05.007. Epub 2018 May 14.

5.

New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.

Walter JE, Heuvelmans MA, Yousaf-Khan U, Dorrius MD, Thunnissen E, Schermann A, Groen HJM, van der Aalst CM, Nackaerts K, Vliegenthart R, de Koning HJ, Oudkerk M.

J Thorac Oncol. 2018 Sep;13(9):1410-1414. doi: 10.1016/j.jtho.2018.05.006. Epub 2018 Jul 12.

6.

High-pitch versus sequential mode for coronary calcium in individuals with a high heart rate: Potential for dose reduction.

Vonder M, Vliegenthart R, Kaatee MA, van der Aalst CM, van Ooijen PMA, de Bock GH, Gratama JW, Kuijpers D, de Koning HJ, Oudkerk M.

J Cardiovasc Comput Tomogr. 2018 Jul - Aug;12(4):298-304. doi: 10.1016/j.jcct.2018.02.005. Epub 2018 Mar 1.

PMID:
29551663
7.

Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening.

Ten Haaf K, van der Aalst CM, de Koning HJ.

Thorax. 2018 May;73(5):407-408. doi: 10.1136/thoraxjnl-2017-211149. Epub 2018 Feb 9. No abstract available.

PMID:
29440512
8.

Coronary Artery Calcium Imaging in the ROBINSCA Trial: Rationale, Design, and Technical Background.

Vonder M, van der Aalst CM, Vliegenthart R, van Ooijen PMA, Kuijpers D, Gratama JW, de Koning HJ, Oudkerk M.

Acad Radiol. 2018 Jan;25(1):118-128. doi: 10.1016/j.acra.2017.07.010. Epub 2017 Aug 23. Review.

PMID:
28843465
9.

Uniform and blinded cause of death verification of the NELSON lung cancer screening participants.

Yousaf-Khan AU, van der Aalst CM, Aerts JGJV, den Bakker MA, de Koning HJ.

Lung Cancer. 2017 Sep;111:131-134. doi: 10.1016/j.lungcan.2017.07.018. Epub 2017 Jul 22.

PMID:
28838383
10.

Bone density loss on computed tomography at 3-year follow-up in current compared to former male smokers.

Pompe E, Bartstra J, Verhaar HJ, de Koning HJ, van der Aalst CM, Oudkerk M, Vliegenthart R, Lammers JJ, de Jong PA, Mohamed Hoesein FAA.

Eur J Radiol. 2017 Apr;89:177-181. doi: 10.1016/j.ejrad.2017.02.011. Epub 2017 Feb 9.

PMID:
28267536
11.

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.

Ten Haaf K, Tammemägi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF.

PLoS Med. 2017 Feb 7;14(2):e1002225. doi: 10.1371/journal.pmed.1002225. eCollection 2017 Feb.

12.

Lung cancer screening: latest developments and unanswered questions.

van der Aalst CM, Ten Haaf K, de Koning HJ.

Lancet Respir Med. 2016 Sep;4(9):749-761. doi: 10.1016/S2213-2600(16)30200-4. Review.

PMID:
27599248
13.

Smokers with emphysema and small airway disease on computed tomography have lower bone density.

Pompe E, de Jong PA, van Rikxoort EM, Gallardo Estrella L, de Jong WU, Vliegenthart R, Oudkerk M, van der Aalst CM, van Ginneken B, Lammers JW, Mohamed Hoesein FA.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 8;11:1207-16. doi: 10.2147/COPD.S103680. eCollection 2016.

14.

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.

Walter JE, Heuvelmans MA, de Jong PA, Vliegenthart R, van Ooijen PMA, Peters RB, Ten Haaf K, Yousaf-Khan U, van der Aalst CM, de Bock GH, Mali W, Groen HJM, de Koning HJ, Oudkerk M.

Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6.

PMID:
27283862
15.

Biochemical verification of the self-reported smoking status of screened male smokers of the Dutch-Belgian randomized controlled lung cancer screening trial.

van der Aalst CM, de Koning HJ.

Lung Cancer. 2016 Apr;94:96-101. doi: 10.1016/j.lungcan.2016.02.001. Epub 2016 Feb 4.

PMID:
26973213
16.

Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?

Scholten ET, de Jong PA, de Hoop B, van Klaveren R, van Amelsvoort-van de Vorst S, Oudkerk M, Vliegenthart R, de Koning HJ, van der Aalst CM, Vernhout RM, Groen HJ, Lammers JW, van Ginneken B, Jacobs C, Mali WP, Horeweg N, Weenink C, Thunnissen E, Prokop M, Gietema HA.

Eur Respir J. 2015 Mar;45(3):765-73. doi: 10.1183/09031936.00005914. Epub 2014 Nov 27. Erratum in: Eur Respir J. 2015 May;45(5):1517.

17.

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Horeweg N, van Rosmalen J, Heuvelmans MA, van der Aalst CM, Vliegenthart R, Scholten ET, ten Haaf K, Nackaerts K, Lammers JW, Weenink C, Groen HJ, van Ooijen P, de Jong PA, de Bock GH, Mali W, de Koning HJ, Oudkerk M.

Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1.

PMID:
25282285
18.

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, de Koning HJ.

Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1.

PMID:
25282284
19.

Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study.

Takx RA, Vliegenthart R, Mohamed Hoesein FA, Išgum I, de Koning HJ, Mali WP, van der Aalst CM, Zanen P, Lammers JW, Groen HJ, van Rikxoort EM, Schmidt M, van Ginneken B, Oudkerk M, Leiner T, de Jong PA.

Eur Radiol. 2015 Jan;25(1):65-71. doi: 10.1007/s00330-014-3384-6. Epub 2014 Sep 3.

PMID:
25182625
20.

Semi-automatic quantification of subsolid pulmonary nodules: comparison with manual measurements.

Scholten ET, de Hoop B, Jacobs C, van Amelsvoort-van de Vorst S, van Klaveren RJ, Oudkerk M, Vliegenthart R, de Koning HJ, van der Aalst CM, Mali WT, Gietema HA, Prokop M, van Ginneken B, de Jong PA.

PLoS One. 2013 Nov 21;8(11):e80249. doi: 10.1371/journal.pone.0080249. eCollection 2013.

21.

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.

Horeweg N, van der Aalst CM, Vliegenthart R, Zhao Y, Xie X, Scholten ET, Mali W, Thunnissen E, Weenink C, Groen HJ, Lammers JW, Nackaerts K, van Rosmalen J, Oudkerk M, de Koning HJ.

Eur Respir J. 2013 Dec;42(6):1659-67. doi: 10.1183/09031936.00197712. Epub 2013 Jul 11.

22.

Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening.

Mets OM, Schmidt M, Buckens CF, Gondrie MJ, Isgum I, Oudkerk M, Vliegenthart R, de Koning HJ, van der Aalst CM, Prokop M, Lammers JW, Zanen P, Mohamed Hoesein FA, Mali WP, van Ginneken B, van Rikxoort EM, de Jong PA.

Respir Res. 2013 May 27;14:59. doi: 10.1186/1465-9921-14-59.

23.

Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K, Weenink C, Groen HJ, Lammers JW, Aerts JG, Scholten ET, van Rosmalen J, Mali W, Oudkerk M, de Koning HJ.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):848-54. doi: 10.1164/rccm.201209-1651OC.

PMID:
23348977
24.

Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?

van der Aalst CM, van Iersel CA, van Klaveren RJ, Frenken FJ, Fracheboud J, Otto SJ, de Jong PA, Oudkerk M, de Koning HJ.

Lung Cancer. 2012 Jul;77(1):51-7. doi: 10.1016/j.lungcan.2012.02.021. Epub 2012 Mar 27.

PMID:
22459203
25.

The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial.

van der Aalst CM, de Koning HJ, van den Bergh KA, Willemsen MC, van Klaveren RJ.

Lung Cancer. 2012 May;76(2):204-10. doi: 10.1016/j.lungcan.2011.10.006. Epub 2011 Nov 4.

PMID:
22054915
26.

The impact of a lung cancer computed tomography screening result on smoking abstinence.

van der Aalst CM, van Klaveren RJ, van den Bergh KA, Willemsen MC, de Koning HJ.

Eur Respir J. 2011 Jun;37(6):1466-73. doi: 10.1183/09031936.00035410. Epub 2010 Dec 9. Erratum in: Eur Respir J. 2011 Aug;38(2):489-90.

27.

Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity?

van der Aalst CM, van Klaveren RJ, de Koning HJ.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):465-78. doi: 10.1016/j.bpg.2010.06.001. Review.

PMID:
20833350
28.

Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial.

van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ.

Thorax. 2010 Jul;65(7):600-5. doi: 10.1136/thx.2009.133751.

PMID:
20627916

Supplemental Content

Loading ...
Support Center